The effect of different physiotherapy interventions in post-BTX-A treatment of children with cerebral palsy

European Journal of Paediatric Neurology

Volumn 16, Issue 1, 2012, Pages 20-28

  Desloovere, K ^a,b   De Cat, J ^a,b   Molenaers, G ^a,b   Franki, I ^c   Himpens, E ^c   Van Waelvelde, H ^c   Fagard, K ^a   Van Den Broeck, C ^c  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c Arteveldehogeschool   (Belgium)

Author keywords

Botulinum toxin; Cerebral Palsy; Physiotherapy

Indexed keywords

BOTULINUM TOXIN A;

ADOLESCENT; ADULT; ARTICLE; CEREBRAL PALSY; CHILD; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; FEMALE; FOLLOW UP; GAIT; GOAL ATTAINMENT SCALE; HUMAN; MALE; PHYSIOTHERAPY; PRIORITY JOURNAL; RATING SCALE; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADOLESCENT; BOTULINUM TOXINS, TYPE A; CEREBRAL PALSY; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MUSCLE SPASTICITY; NEUROMUSCULAR AGENTS; PHYSICAL THERAPY MODALITIES; RETROSPECTIVE STUDIES; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 84655167110     PISSN: 10903798     EISSN: 15322130     Source Type: Journal    
DOI: 10.1016/j.ejpn.2011.08.009     Document Type: Article

References (33)

1. J.R. Gage The treatment of gait problems in cerebral palsy 2004 Mc Keith Press London
2. M. Rang Paediatric orthopaedics 3rd ed. 1990 Philadelphia
3. C. Christine, H. Dolk, and M.J. Platt Recommendations for the SCPE collaborative group for defining and classifying cerebral palsy Dev Med Child Neur 109 2007 35 38 (Pubitemid 46336270)
4. R. Boyd, and H.K. Graham Botulinum Toxin A in the management of children with cerebral palsy: indications and outcome Eur J Neurol 4 1997 15 22
5. J. Wissel, F. Heinen, A. Schenkel, and B. Doll Botulinum Toxin A in the management of spastic gait disorders in children and young adults with cerebral palsy: a randomized, double-blind study of 'high-dose' versus 'low-dose' treatment Neuropediatrics 30 1999 120 124 (Pubitemid 29366681)
6. L.A. Koman, B.P. Smith, and R. Balkrishan Spasticity associated with cerebral palsy in children; guidelines for the use of Botulinum Toxin A Paed Drugs 5 2003 11 23 (Pubitemid 36127021)
7. I.S. Corry, A.P. Cosgrove, and C.M. Duffy Botulinum Toxin A compared with stretching casts in the treatment of spastic equines: a randomized prospective trial J Paed Orthop 18 1998 304 311 (Pubitemid 28212938)
8. M. Bottos, M.G. Benedetti, and P. Salucci Botulinum Toxin with and without casting in ambulant children with spastic bilateral CP: a clinical and functional assessment Dev Med Child Neurol 45 2003 758 762 (Pubitemid 37304065)
9. K. Desloovere, G. Molenaers, and I. Jonkers A randomized study of combined toxin type A and casting in the ambulant child with cerebral palsy using outcome objectives Eur J Neurol 8 2001 75 87 (Pubitemid 33757693)
10. V.A. Scholtes, A.J. Dallmeijer, and D.L. Knol The combined effect of lower limb multilevel Botulinum Toxin Type A injections and comprehensive rehabilitation on mobility in children with cerebral palsy: a randomized clinical trial Arch Phys Med Rehab 87 2006 1551 1558 (Pubitemid 44821066)
11. G. Molenaers, K. Desloovere, and M. Eyssen Botulinum Toxin A treatment of cerebral palsy: an integrated approach Eur J Neurol 6 1999 51 57
12. F. Heinen, G. Molenaers, and C. Fairhust European consensus table 2006 on Botulinum Toxin for children with cerebral palsy Eur J Paed Neurol 10 2006 215 225 (Pubitemid 44815258)
13. A.S. Papavasiliou Management of motor problems in cerebral palsy: a critical update for the clinician Eur J Paed Neurol 28 2 2008 213 217
14. G. Molenaers, K. Desloovere, and G. Fabry The effects of quantitative gait assessment and botulinum toxin on a musculoskeletal surgery in children with Cerebral Palsy J Bone Jt Surg 88 2006 161 170 (Pubitemid 43062784)
15. J. Leach Children undergoing treatment with Botulinum Toxin: the role of the physical therapist Muscle&Nerve 20 1997 194 207
16. S. Raine The current theoretical assumptions of the Bobath concept as determined by the members of the BBTA Phys Ther Pract 3 2007 137 152 (Pubitemid 46897705)
17. International Bobath Instructors Training Association. Theoretical assumptions [Internet]. http://www.ibita.org. accessed 7.04.09.
18. G.L. Girolami, and S.K. Campbell Efficacy of a neurodevelopmental treatment program to improve motor control in infants bron prematurely Pediatr Phys Ther 6 1994 175 184
19. V. Knox, and A.E. Lloyd Evaluation of the functional effects of a course of Bobath therapy in children with cerebral palsy: a preliminary study Dev Med Child Neurol 44 2002 447 460 (Pubitemid 34808752)
20. N. Tsorlakis, C. Evaggelinou, and G. Grouios Effect of a neurodevelopmental treatment in Gross motor function of cerebral palsy Dev Med Child Neurol 46 2004 740 745 (Pubitemid 39468021)
21. C. Butler, and J. Darrah Effects of Neurodevelopment Treatment (NDT) for cerebral palsy: an AACPDM evidence report Dev Med Child Neur 43 2001 778 790 (Pubitemid 33054171)
22. H. Antila, J. Suoranta, A. Malmivaara, M. Mäkelä, and I. Autti-Rämö Effectiveness of physiotherapy and conductive education interventions in children with cerebral palsy: a focused review Am J Phys Med Rehab 87 2008 478 501
23. V.A. Scholtes, A.J. Dallmeijer, and D.L. Knol Effect of a multilevel Botulinum Toxin A and comprehensive rehabilitation on gait in cerebral palsy Ped Neurol 36 2007 30 39 (Pubitemid 46427789)
24. L.A.W.M. Speth, P. Leffers, and Y.J.M. Janssen-Potten Botulinum toxin A and upper limb functional skills in hemiparetic cerebral palsy: a randomized trial in children receiving intensive physiotherapy Dev Med Child Neurol 47 2005 468 473 (Pubitemid 40895412)
25. N. Lannin, A. Scheinberg, and K. Clark AACPDM systematic evidence report of therapy for children with cerebral palsy after Botulinum Toxin A injections Dev Med Child Neurol 47 2006 533 539 (Pubitemid 43740920)
26. T.J. Kirusek, A. Smith, and J.E. Cardillo Goals attainment scaling: applications, theory and measurement 1994 Laurence Erlbaum Associates Hillsdale, New Jersy
27. R.J. Palisano Validity of goal attainment scaling in infants with motor delays Phys Ther 73 1993 651 660 (Pubitemid 23308025)
28. Z. Mailloux Goal attainment scaling as a measure of meaningful outcomes for children with sensory integration disorders Am J Occup Ther 61 2007 254 259
29. D.M. Weigl, N. Arbel, K. Katz, T. Becker, and N. Bar-Or Botulinum toxin for the treatment of spasticity in children: attainment of treatment goals J Pediatr Orthop 16 2007 293 296 (Pubitemid 47165424)
30. T.J.H. Bovend'Eerdt, E.R. Botell, and D.T. Wade Writing SMART rehabilitation goals and achieving goal attainment scaling: a practical guide Clin Rehab 23 2009 352 361
31. K. Desloovere, V. Schörkhuber, and K. Fagard Botulinum Toxin Type A treatment in children with cerebral palsy: Evaluation of treatment success or failure by means of goal attainment scaling Eur J Paediatric Neurol 2011 Aug 13 [Epub ahead of print]
32. G. Molenaers, V. Schörkhuber, R. Fagard, C. Huenaerts, A. Van Campenhout, J. De Cat, P. Pauwels, E. Ortibus, P. De Cock, and K. Desloovere Long-term use of Botulinum Toxin Type A in children with cerebral palsy: treatment consistency Eur J Paediatric Neurol 13 5 2009 421 429
33. Mayston MJ. The Bobath Concept today. In: 2000. http://www.bobath.org.uk/ concepttoday.php; February 2011.